A Win For Novus Therapeutics, Inc.
Fri, Oct 30, 2020 at 05:30 PM
Novus Therapeutics, Inc. (NVUS:NASDAQ) shot up at $26.18, representing a gain of 22.2%. On Thu 29 Oct 20, NVUS:NASDAQ hit a New 2-Week High of $21.42. The stock appeared on our News Catalysts scanner on Fri 09 Oct 20 at 03:57 AM in the 'SPLIT' category. From Thu 15 Oct 20, the stock recorded 50.00% Up Days and 36.36% Green Days
About Novus Therapeutics, Inc. (NVUS:NASDAQ)
Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.
Top 10 Gainers:
- BioLineRx Ltd. (BLRX:NASDAQ), 33.78%
- Tricida, Inc. (TCDA:NASDAQ), 28.83%
- Air Industries Group (AIRI:NYSEMKT), 27.82%
- Daseke, Inc. (DSKE:NASDAQ), 26.59%
- Build-A-Bear Workshop, Inc. (BBW:NYSE), 24.4%
- Acadia Healthcare Company, Inc. (ACHC:NASDAQ), 23.02%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 22.22%
- MICT, Inc. (MICT:NASDAQ), 21.88%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 21.76%
- LNSR (LNSR:NASDAQ), 19.61%